ArticleFrontiers in oncology2020

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy.

Meilin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.